Migraine relief: New drug may start working right away
A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology. The study looked at the drug atogepant, which is a calcitonin ...
Dec 23, 2024
0
170
Clinical trial shows propranolol reduces tremors in Parkinson's disease
The standard medication levodopa does not always work against tremors in Parkinson's disease, especially in stressful situations. Propranolol, however, does work during stress, providing insight into the role of the stress ...
Dec 23, 2024
0
69
GLP-1 Zepbound is approved as first drug for sleep apnea
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.
Dec 23, 2024
0
23
Plant-based extract shows potential for psoriasis treatment
A research group has made significant progress in investigating the therapeutic effects and molecular mechanisms of stilbene-enriched extracts from the leaves of Cajanus cajan (L.) Millsp.(C. cajan) as a potential therapeutic ...
Dec 23, 2024
0
0
Upadacitinib found to improve ulcerative colitis outcomes at 12 months
For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a study published in the December issue of the American Journal ...
Dec 23, 2024
0
0
FDA expands approval of Vtama to include atopic dermatitis
The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 years and older.
Dec 20, 2024
0
1
FDA says shortage of GLP-1 tirzepatide is over
The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss med tirzepatide is over.
Dec 19, 2024
0
0
What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices
Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential ...
Dec 19, 2024
0
0
Reducing dose of popular blood thinners may limit risk of future bleeding, study finds
For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.
Dec 19, 2024
0
0
Nucleic acid drug iSN40 shows promise for osteoporosis treatment
Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has highlighted the role of osteogenic CpG oligodeoxynucleotide (iSN40) in promoting osteoblast differentiation ...
Dec 19, 2024
0
2
What is metformin's secret sauce? New study shows how 'wonder drug' works in living animals
Millions of people take metformin, a type 2 diabetes medication that lowers blood sugar. The "wonder drug" has also been shown to slow cancer growth, improve COVID outcomes and reduce inflammation. But until now, scientists ...
Dec 18, 2024
0
115
Managing adult ADHD: Comprehensive study compares stimulants, atomoxetine and non-pharmacological therapies
Stimulants and atomoxetine are the only effective interventions to reduce short-term adult ADHD symptoms, yet show limited evidence for long-term outcomes and quality of life improvements, according to a study by the University ...
Common cough syrup ingredient offers hope for lung fibrosis patients
A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.
Dec 18, 2024
1
59
Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug
The new gene therapies for sickle cell disease—including the gene-editing treatment Casgevy, based on research at Boston Children's Hospital—have been game-changing for the patients who have received them. But Stuart ...
Dec 18, 2024
0
27
Psychedelics boost mystical experiences during meditation, DMT study finds
Researchers assessed whether combining psychedelics, namely DMT and harmine as two active ingredients in ayahuasca, with meditation increases mindfulness, compassion, insight, and mystical-type transcendence to a higher degree ...
Dec 18, 2024
0
0
How do multiple sclerosis drugs affect pregnancy?
Many women are diagnosed with multiple sclerosis (MS) at an age when they are considering starting a family. What does the disease and its medication mean for the child? To answer this question, a research team headed by ...
Dec 18, 2024
0
0
Some racial and ethnic groups may face barriers to obtaining obesity medications
Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications to lower their weight compared with whites, new research suggests. The differences could not be fully ...
Dec 18, 2024
1
0
Clopidogrel edges out aspirin in heart procedure recovery
Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) experienced lower rates of both thrombotic and bleeding events than those taking aspirin. Clopidogrel's ...
Horseshoe crab and tarantula-derived peptides may provide key to beating drug-resistant melanoma
Antimicrobial peptides derived from a crab and a spider may provide the pathway to overcoming drug resistance in advanced melanoma. QUT researchers based at Brisbane's Translational Research Institute (TRI) have modified ...
Dec 16, 2024
0
22
Diabetes drug linked to increased risk of severe eye condition
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye, ...
Dec 16, 2024
0
91
Study explores whether CBD can reduce scan-related anxiety in patients with advanced breast cancer
Anxiety is extremely common among adults receiving cancer care, with as many as one out of every four patients meeting the clinical criteria for anxiety.
Dec 16, 2024
0
0
Researchers call for action to tackle global antibiotic shortages
Antibiotic shortages disrupt patient care, increase treatment costs, reduce effectiveness, and contribute to the rise of antibiotic resistance globally.
Dec 16, 2024
0
0
St John's wort: Six drug interactions you should know about
St John's wort is an herbal supplement that has been used for centuries to boost mood. Even today, many people use it as a natural treatment for mild to moderate depression. St John's wort contains several active compounds, ...
Dec 16, 2024
0
0